1Department of Nursing, Jesus University, Jeonju, Korea
2College of Nursing, Research Institute of Nursing Science, Jeonbuk National University, Jeonju, Korea
© 2025 Korean Society of Nursing Science
This is an Open Access article distributed under the terms of the Creative Commons Attribution NoDerivs License (http://creativecommons.org/licenses/by-nd/4.0) If the original work is properly cited and retained without any modification or reproduction, it can be used and re-distributed in any format and medium.
H1. The experimental group receiving an IMCHB-based lifestyle intervention would reveal greater improvement in HPB than the control group.
H2. The experimental group receiving an IMCHB-based lifestyle intervention would exhibit lower infertility stress than the control group.
H3. The experimental group receiving an IMCHB-based lifestyle intervention would demonstrate greater improvements in fertility-related quality of life than the control group.
H4. The experimental group receiving an IMCHB-based lifestyle intervention would demonstrate better sperm quality (volume, total motility, immobility, concentration, and normal morphology) than the control group.
• Sperm volume: ≥1.5 mL, measured using a sterilized syringe.
• Total motility: ≥40%, including both progressive and non-progressive motility.
• Immobility: Percentage of non-moving sperm.
• Concentration: ≥15 million sperm/mL.
• Normal morphology: ≥4%, indicating sperm with normal size, shape, and structure. Abnormalities in sperm morphology, such as those in the head, mid piece, or tail, can reduce reproductive capacity.
Conflicts of Interest
No potential conflict of interest relevant to this article was reported.
Acknowledgements
None.
Funding
This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (No., NRF-2020R1F1A1050767).
Data Sharing Statement
Please contact the corresponding author for data availability.
Author Contributions
Conceptualization or/and Methodology: YMK, JHN. Data curation or/and Analysis: YMK, JHN. Funding acquisition: JHN. Investigation: JHN. Project administration or/and Supervision: JHN. Resources or/and Software: YMK, JHN. Validation: YMK, JHN. Visualization: YMK, JHN. Writing: original draft or/and Review & Editing: YMK, JHN. Final approval of the manuscript: YMK, JHN.
Values are presented as median (interquartile range) or mean±standard deviation.
Cont., control group; Exp., experimental group; IMCHB, interaction model of client health behavior.
a)By Mann-Whitney U test. b)By independent t-test. c)By ranked analysis of covariance (covariate: pre-test score of total motility and immobility).
Session: 1, 3, 5, 7, 9, 11, 13, 15 (every Tuesday for 8 weeks) | Session: 2, 4, 6, 8, 10, 12, 14, 16 (every Friday for 8 weeks) | Session: daily | Elements of client professional interaction | |||
---|---|---|---|---|---|---|
Education | Method | Feedback | Method | Monitoring | Method | |
Reproductive health education | Digital short message service | Consultation | Telephone | Self-checking | Wearable device | Client professional interaction |
- Reproductive health for men and women | - Individualized feedback | - Assessing the lifestyle patterns via lifestyle checklist | Uniform resource locator | - Text messages | ||
- Lifestyle factors affecting fertility | - Recommendations on optimizing their physical activity, dietary habits, and stress management strategies. | - Monitoring | ||||
- Lifestyle modification strategies for optimizing reproductive outcomes | - Telephone consultations and monitoring | |||||
Physical activity management | - Assessment of exercise, diet, and stress status | |||||
- Intensity and method of walking | Health information | |||||
- Methods of strength training and aerobic exercise | - Education and information | |||||
- Precautions during physical activity | - Knowledge reinforcement | |||||
- How to use a smart band and a physical activity diary | Professional/technical competencies | |||||
Nutritional management | - Telephone and individual counseling | |||||
- Men’s healthy diet and nutrition education | - Decisional control: phone calls and mobile messages | |||||
- Nutrition label confirmation | Affective support | |||||
- Nutritional education related to reproductive health | - Praise | |||||
- 24-hour dietary recall | - Encouragement | |||||
Stress management | - Support | |||||
- Relaxation and mindfulness techniques (meditation, bedtime relaxation) | ||||||
- Talking with one’s spouse (before going to bed, taking a walk) | ||||||
- Sufficient sleep (about 7 hours) | ||||||
- Light walking with one’s spouse |
Characteristic | Exp. (n=17) | Cont. (n=19) | χ2 or t or z | p |
---|---|---|---|---|
n (%)/M±SD/med (IQR) | ||||
Age (yr) | 0.15 | .881 | ||
≤30 | 1 (5.9) | 0 (0.0) | ||
31–34 | 5 (29.4) | 8 (42.1) | ||
35–40 | 5 (29.4) | 5 (26.3) | ||
≥41 | 6 (35.3) | 6 (31.6) | ||
Mean±SD | 37.24±4.76 | 38.00±5.16 | ||
Age of spouse (yr) | 0.99 | .804 | ||
≤30 | 3 (17.7) | 2 (10.5) | ||
31–34 | 5 (29.4) | 8 (42.1) | ||
35–40 | 4 (23.5) | 4 (21.1) | ||
≥41 | 5 (29.4) | 5 (26.3) | ||
Mean±SD | 34.94±4.48 | 35.42±4.49 | ||
Marriage duration (mo) | 5.55 | .136 | ||
≤24 | 3 (17.7) | 5 (26.3) | ||
25–36 | 5 (29.4) | 5 (26.3) | ||
37–48 | 4 (23.5) | 0 (0.0) | ||
≥49 | 5 (29.4) | 9 (47.4) | ||
Mean±SD | 49.18±35.91 | 53.89±36.18 | ||
Religion | 1.99 | .192 | ||
Yes | 12 (70.6) | 9 (47.4) | ||
No | 5 (29.4) | 10 (52.6) | ||
Education | 0.96 | .434 | ||
≤High school | 5 (29.4) | 3 (15.8) | ||
≥University | 12 (70.6) | 16 (84.2) | ||
Chronic disease | 0.01 | >.999 | ||
Yes | 1 (5.9) | 1 (5.3) | ||
No | 16 (94.1) | 18 (94.7) | ||
Monthly individual income (10,000 KRW) | 1.14 | .887 | ||
<200 | 1 (5.9) | 1 (5.3) | ||
200–299 | 5 (29.4) | 6 (31.6) | ||
300–399 | 3 (17.7) | 2 (10.5) | ||
400–499 | 4 (23.5) | 3 (15.8) | ||
≥500 | 4 (23.5) | 7 (36.8) | ||
Alcohol consumption | 0.63 | .502 | ||
Yes | 12 (70.6) | 11 (57.9) | ||
No | 5 (29.4) | 8 (42.1) | ||
Smoking | 0.39 | .695 | ||
Yes | 3 (17.7) | 5 (26.3) | ||
No | 14 (82.3) | 14 (73.7) | ||
Physical activity | 0.01 | >.999 | ||
Yes | 6 (35.3) | 7 (36.8) | ||
No | 11 (64.7) | 12 (63.2) | ||
Sleeping hours (hr) | 2.73 | .158 | ||
<3 | 1 (5.9) | 0 (0.0) | ||
3–5 | 7 (41.2) | 2 (10.5) | ||
6–7 | 7 (41.2) | 14 (73.7) | ||
≥8 | 2 (11.7) | 3 (15.8) | ||
Body mass index (kg/m2) | 26.07±3.39 | 25.40±3.11 | 0.62 | .540 |
Normal (18.5–24.9) | 8 (47.1) | 6 (35.3) | ||
Overweight (18.5–24.9) | 5 (29.4) | 6 (35.3) | 1.12 | .570 |
Obesity (≥30.0) | 4 (23.5) | 5 (29.4) | ||
Semen analysis experience | 0.39 | .736 | ||
Yes | 8 (47.1) | 7 (36.8) | ||
No | 9 (52.9) | 12 (63.2) | ||
Health-promoting behaviors | 117.00 (IQR, 109.00) | 113.00 (IQR, 104.00) | –0.65a) | .516 |
Infertility stress | 166.00±19.98 | 149.58±27.55 | 2.03 | .051 |
Fertility-related quality of life | 72.37±11.47 | 70.27±10.89 | 0.56 | .577 |
Volume (mL) (n=30) | 4.00 (IQR, 3.00) | 3.50 (IQR, 2.75) | –0.49a) | .626 |
Total motility (%) (n=30) | 64.98 (IQR, 41.39) | 83.84 (IQR, 76.33) | –2.03a) | .042 |
Immobility (%) (n=30) | 35.02 (IQR, 13.60) | 16.16 (IQR< 8.86) | 2.97a) | .007 |
Concentration (million/mL) (n=30) | 25.53 (IQR, 13.26) | 36.40 (IQR, 21.25) | –1.57a) | .117 |
Normal morphology (%) (n=30) | 9.98 (IQR, 8.12) | 19.76 (IQR, 11.74) | –1.47a) | .143 |
Variable | Pre-test | Post-test | Difference | z or t or F | p |
---|---|---|---|---|---|
Med (IQR)/M±SD | |||||
Health promoting behaviors | –2.27a) | .023 | |||
Exp. (n=17) | 117.00 (109.00) | 132.00 (125.00) | 8.00 (1.00) | ||
Cont. (n=19) | 113.00 (104.00) | 119.00 (104.00) | –1.00 (–5.00) | ||
Infertility stress | –2.40b) | .022 | |||
Exp. (n=17) | 166.00±19.98 | 114.53±22.59 | –51.47±34.35 | ||
Cont. (n=19) | 149.58±27.55 | 126.79±26.00 | –22.79±37.18 | ||
Fertility-related quality of life | 0.63b) | .531 | |||
Exp. (n=17) | 72.37±11.47 | 74.12±6.88 | 1.76±10.08 | ||
Cont. (n=19) | 70.26±10.89 | 69.70±11.74 | –0.57±11.74 | ||
Volume (mL) (n=30) | –0.49a) | .626 | |||
Exp. (n=17) | 4.00 (3.00) | 4.00 (4.00) | 0.00 (0.00) | ||
Cont. (n=13) | 3.50 (2.75) | 3.00 (2.00) | 0.00 (0.00) | ||
Total motility (%) (n=30) | 4.39c) | .045 | |||
Exp. (n=17) | 64.98 (41.39) | 86.09 (72.83) | 16.33 (1.67) | ||
Cont. (n=13) | 83.84 (76.33) | 90.43 (70.24) | 0.00 (–8.74) | ||
Immobility (%) (n=30) | 2.04c) | .164 | |||
Exp. (n=17) | 35.02 (13.60) | 13.92 (10.98) | –16.33 (–31.45) | ||
Cont. (n=13) | 16.16 (8.86) | 9.57 (6.40) | –0.61 (–8.54) | ||
Concentration (million/mL) (n=30) | –1.57a) | .117 | |||
Exp. (n=17) | 25.53 (13.26) | 34.41 (17.67) | 3.92 (–4.44) | ||
Cont. (n=13) | 36.40 (21.25) | 51.11 (21.79) | 2.03 (–6.80) | ||
Normal morphology (%) (n=30) | 2.86a) | .017 | |||
Exp. (n=17) | 9.98 (8.12) | 23.55 (9.91) | 2.52 (0.02) | ||
Cont. (n=13) | 19.76 (11.74) | 17.48 (9.95) | –0.23 (–10.24) |
IMCHB, interaction model of client health behavior.
Values are presented as number (%), mean±SD, or median (IQR). Cont., control group; Exp., experimental group; IQR, interquartile range; KRW, Korean won; SD, standard deviation. By Mann-Whitney U test.
Values are presented as median (interquartile range) or mean±standard deviation. Cont., control group; Exp., experimental group; IMCHB, interaction model of client health behavior. a)By Mann-Whitney U test. b)By independent t-test. c)By ranked analysis of covariance (covariate: pre-test score of total motility and immobility).